0001485003-20-000012.txt : 20200218 0001485003-20-000012.hdr.sgml : 20200218 20200218165728 ACCESSION NUMBER: 0001485003-20-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200213 FILED AS OF DATE: 20200218 DATE AS OF CHANGE: 20200218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Mark CENTRAL INDEX KEY: 0001331843 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 20626101 MAIL ADDRESS: STREET 1: 1000 BISHOPS GATE BOULEVARD STREET 2: SUITE 300 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 4 1 wf-form4_158206303194870.xml FORM 4 X0306 4 2020-02-13 0 0001485003 Sesen Bio, Inc. SESN 0001331843 Sullivan Mark C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 0 1 0 0 General Counsel & Secretary Employee Stock Option (Right to Buy) 0.8911 2020-02-13 4 A 0 260000 0 A 2030-02-13 Common Stock 260000.0 260000 D On February 13, 2020, the reporting person was awarded options to purchase 260,000 shares of the common stock of Sesen Bio, Inc. (the "Company"), which options vest 6.25% every three months over four years provided the reporting person is employed by the Company at each such vesting date. /s/ Mark R. Sullivan 2020-02-18